Self-injection Devices Market Size, Share & Trends Analysis By Product (Auto Injectors, Pen Injectors), By Usability (Disposable, Reusable), By Application (Cancer, Autoimmune Disorders, Hormonal Disorders), By Region, And Segment Forecasts, 2025 - 2030

Self-injection Devices Market Size, Share & Trends Analysis By Product (Auto Injectors, Pen Injectors), By Usability (Disposable, Reusable), By Application (Cancer, Autoimmune Disorders, Hormonal Disorders), By Region, And Segment Forecasts, 2025 - 2030


U.S. Beauty And Personal Care Products Market Growth & Trends

The U.S. beauty and personal care products market is anticipated to reach USD 155.44 billion by 2030, according to a new report by Grand View Research, Inc. The market is projected to grow at a CAGR of 7.1% from 2025 to 2030. The market is witnessing robust growth, largely propelled by evolving consumer preferences, increasing awareness of product ingredients, and a strong shift toward sustainable and ethical consumption. In recent years, there has been a pronounced focus on wellness, extending beyond traditional beauty parameters, driving demand for products that align with a holistic and health-oriented lifestyle. As of 2023, this market has been expanding steadily, driven by the rise in disposable income and changing lifestyles across diverse demographic groups. This growth trajectory has created a fertile environment for innovation, enabling companies to diversify their offerings to cater to increasingly sophisticated and conscientious consumers.

A major trend shaping the U.S. beauty landscape is the surging demand for Please note The report will be delivered in 2-3 business days upon order notification.


Chapter 1. Methodology and Scope
1.1. Market Segmentation and Scope
1.2. Segment Definitions
1.2.1. Product
1.2.2. Application
1.2.3. End-Use
1.2.4. Regional scope
1.2.5. Estimates and forecasts timeline
1.3. Research Methodology
1.4. Information Procurement
1.4.1. Purchased database
1.4.2. GVR’s internal database
1.4.3. Secondary sources
1.4.4. Primary research
1.4.5. Details of primary research
1.4.5.1. Data for primary interviews in North America
1.4.5.2. Data for primary interviews in Europe
1.4.5.3. Data for primary interviews in Asia Pacific
1.4.5.4. Data for primary interviews in Latin America
1.4.5.5. Data for Primary interviews in MEA
1.5. Information or Data Analysis
1.5.1. Data analysis models
1.6. Market Formulation & Validation
1.7. Model Details
1.7.1. Commodity flow analysis (Model 1)
1.7.2. Approach 1: Commodity flow approach
1.7.3. Volume price analysis (Model 2)
1.7.4. Approach 2: Volume price analysis
1.8. List of Secondary Sources
1.9. List of Primary Sources
1.10. Objectives
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Product outlook
2.2.2. Application outlook
2.2.3. End Use outlook
2.3. Regional outlook
2.4. Competitive Insights
Chapter 3. Self-injection Devices Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent Market Outlook
3.1.2. Related/ancillary market outlook
3.2. Market Dynamics
3.2.1. Market Driver Analysis
3.2.1.1. Increasing preference for self-administration
3.2.1.2. Rising prevalence of hormonal disorders
3.2.1.3. Technological advancements
3.2.2. Market Restraint Analysis
3.2.2.1. Risk of Infection and Complications
3.3. Self-injection Devices Market Analysis Tools
3.3.1. Industry Analysis - Porter’s
3.3.1.1. Bargaining power of suppliers
3.3.1.2. Bargaining power of buyers
3.3.1.3. Threat of substitutes
3.3.1.4. Threat of new entrants
3.3.1.5. Competitive rivalry
3.3.2. PESTEL Analysis
3.3.2.1. Political landscape
3.3.2.2. Economic landscape
3.3.2.3. Social landscape
3.3.2.4. Technological landscape
3.3.2.5. Environmental landscape
3.3.2.6. Legal landscape
Chapter 4. Self-injection Devices Market: Product Estimates & Trend Analysis
4.1. Segment Dashboard
4.2. Self-injection Devices Market: Product Movement Analysis
4.3. Self-injection Devices Market by Product Outlook (USD Million)
4.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
4.5. Autoinjectors
4.5.1. Autoinjectors Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.6. Pen injectors
4.6.1. Pen injectors Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.7. Wearable injectors
4.7.1. Wearable injectors Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.8. Needle-free injectors
4.8.1. Needle-free injectors Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 5. Self-injection Devices Market: Usability Estimates & Trend Analysis
5.1. Segment Dashboard
5.2. Self-injection Devices Market: Usability Movement Analysis
5.3. Self-injection Devices Market by Usability Outlook (USD Million)
5.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
5.5. Disposable
5.5.1. Disposable Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.6. Reusable
5.6.1. Reusable Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 6. Self-injection Devices Market: Application Estimates & Trend Analysis
6.1. Segment Dashboard
6.2. Self-injection Devices Market: Application Movement Analysis
6.3. Self-injection Devices Market by Application Outlook (USD Million)
6.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
6.5. Cancer
6.5.1. Cancer Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
6.6. Autoimmune disorders
6.6.1. Autoimmune disorders Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
6.7. Pain management
6.7.1. Pain management Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
6.8. Others
6.8.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 7. Self-injection Devices Market: Regional Estimates & Trend Analysis
7.1. Regional Dashboard
7.2. Regional Self-injection Devices Market Movement Analysis
7.3. Self-injection Devices Market: Regional Estimates & Trend Analysis by Technology & End-use
7.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
7.5. North America
7.5.1. North America Self-injection Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.5.2. U.S.
7.5.2.1. Key Country Dynamics
7.5.2.2. Competitive Scenario
7.5.2.3. Regulatory Framework
7.5.2.4. Reimbursement scenario
7.5.2.5. U.S. Self-injection Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.5.3. Canada
7.5.3.1. Key Country Dynamics
7.5.3.2. Competitive Scenario
7.5.3.3. Regulatory Framework
7.5.3.4. Reimbursement scenario
7.5.3.5. Canada Self-injection Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.5.4. Mexico
7.5.4.1. Key Country Dynamics
7.5.4.2. Competitive Scenario
7.5.4.3. Regulatory Framework
7.5.4.4. Reimbursement scenario
7.5.4.5. Mexico Self-injection Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.5.5. Europe
7.5.6. Europe Self-injection Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.5.7. UK
7.5.7.1. Key Country Dynamics
7.5.7.2. Competitive Scenario
7.5.7.3. Regulatory Framework
7.5.7.4. Reimbursement scenario
7.5.7.5. UK Self-injection Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.5.8. Germany
7.5.8.1. Key Country Dynamics
7.5.8.2. Competitive Scenario
7.5.8.3. Regulatory Framework
7.5.8.4. Reimbursement scenario
7.5.8.5. Germany Self-injection Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.5.9. France
7.5.9.1. Key Country Dynamics
7.5.9.2. Competitive Scenario
7.5.9.3. Regulatory Framework
7.5.9.4. Reimbursement scenario
7.5.9.5. France Self-injection Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.5.10. Italy
7.5.10.1. Key Country Dynamics
7.5.10.2. Competitive Scenario
7.5.10.3. Regulatory Framework
7.5.10.4. Reimbursement scenario
7.5.10.5. Italy Self-injection Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.5.11. Spain
7.5.11.1. Key Country Dynamics
7.5.11.2. Competitive Scenario
7.5.11.3. Regulatory Framework
7.5.11.4. Reimbursement scenario
7.5.11.5. Spain Self-injection Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.5.12. Denmark
7.5.12.1. Key Country Dynamics
7.5.12.2. Competitive Scenario
7.5.12.3. Regulatory Framework
7.5.12.4. Reimbursement scenario
7.5.12.5. Denmark Self-injection Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.5.13. Sweden
7.5.13.1. Key Country Dynamics
7.5.13.2. Competitive Scenario
7.5.13.3. Regulatory Framework
7.5.13.4. Reimbursement scenario
7.5.13.5. Sweden Self-injection Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.5.14. Norway
7.5.14.1. Key Country Dynamics
7.5.14.2. Competitive Scenario
7.5.14.3. Regulatory Framework
7.5.14.4. Reimbursement scenario
7.5.14.5. Norway Self-injection Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.6. Asia Pacific
7.6.1. Asia Pacific Self-injection Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.6.2. Japan
7.6.2.1. Key Country Dynamics
7.6.2.2. Competitive Scenario
7.6.2.3. Regulatory Framework
7.6.2.4. Reimbursement scenario
7.6.2.5. Japan Self-injection Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.6.3. China
7.6.3.1. Key Country Dynamics
7.6.3.2. Competitive Scenario
7.6.3.3. Regulatory Framework
7.6.3.4. Reimbursement scenario
7.6.3.5. China Self-injection Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.6.4. India
7.6.4.1. Key Country Dynamics
7.6.4.2. Competitive Scenario
7.6.4.3. Regulatory Framework
7.6.4.4. Reimbursement scenario
7.6.4.5. India Self-injection Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.6.5. South Korea
7.6.5.1. Key Country Dynamics
7.6.5.2. Competitive Scenario
7.6.5.3. Regulatory Framework
7.6.5.4. Reimbursement scenario
7.6.5.5. South Korea Self-injection Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.6.6. Australia
7.6.6.1. Key Country Dynamics
7.6.6.2. Competitive Scenario
7.6.6.3. Regulatory Framework
7.6.6.4. Reimbursement scenario
7.6.6.5. Australia Self-injection Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.6.7. Thailand
7.6.7.1. Key Country Dynamics
7.6.7.2. Competitive Scenario
7.6.7.3. Regulatory Framework
7.6.7.4. Reimbursement scenario
7.6.7.5. Thailand Self-injection Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.7. Latin America
7.7.1. Latin America Self-injection Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.7.2. Brazil
7.7.2.1. Key Country Dynamics
7.7.2.2. Competitive Scenario
7.7.2.3. Regulatory Framework
7.7.2.4. Reimbursement scenario
7.7.2.5. Brazil Self-injection Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.7.3. Argentina
7.7.3.1. Key Country Dynamics
7.7.3.2. Competitive Scenario
7.7.3.3. Regulatory Framework
7.7.3.4. Reimbursement scenario
7.7.3.5. Argentina Self-injection Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.8. Middle East & Africa
7.8.1. Middle East & Africa Self-injection Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.8.2. South Africa
7.8.2.1. Key Country Dynamics
7.8.2.2. Competitive Scenario
7.8.2.3. Regulatory Framework
7.8.2.4. Reimbursement scenario
7.8.2.5. South Africa Self-injection Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.8.3. Saudi Arabia
7.8.3.1. Key Country Dynamics
7.8.3.2. Competitive Scenario
7.8.3.3. Regulatory Framework
7.8.3.4. Reimbursement scenario
7.8.3.5. Saudi Arabia Self-injection Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.8.4. UAE
7.8.4.1. Key Country Dynamics
7.8.4.2. Competitive Scenario
7.8.4.3. Regulatory Framework
7.8.4.4. Reimbursement scenario
7.8.4.5. UAE Self-injection Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.8.5. Kuwait
7.8.5.1. Key Country Dynamics
7.8.5.2. Competitive Scenario
7.8.5.3. Regulatory Framework
7.8.5.4. Reimbursement scenario
7.8.5.5. Kuwait Self-injection Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 8. Competitive Landscape
8.1. Market Participant Categorization
8.2. Key Company Profiles
8.2.1. YPSOMED
8.2.1.1. Company overview
8.2.1.2. Financial performance
8.2.1.3. Product benchmarking
8.2.1.4. Strategic initiatives
8.2.2. BD
8.2.2.1. Company overview
8.2.2.2. Financial performance
8.2.2.3. Product benchmarking
8.2.2.4. Strategic initiatives
8.2.3. Gerresheimer AG
8.2.3.1. Company overview
8.2.3.2. Financial performance
8.2.3.3. Product benchmarking
8.2.3.4. Strategic initiatives
8.2.4. Antares Pharma, Inc.
8.2.4.1. Company overview
8.2.4.2. Financial performance
8.2.4.3. Product benchmarking
8.2.4.4. Strategic initiatives
8.2.5. Haselmeier AG
8.2.5.1. Company overview
8.2.5.2. Financial performance
8.2.5.3. Product benchmarking
8.2.5.4. Strategic initiatives
8.2.6. NuGen Medical Devices
8.2.6.1. Company overview
8.2.6.2. Financial performance
8.2.6.3. Product benchmarking
8.2.6.4. Strategic initiatives
8.2.7. Owen Mumford Ltd.
8.2.7.1. Company overview
8.2.7.2. Financial performance
8.2.7.3. Product benchmarking
8.2.7.4. Strategic initiatives
8.2.8. SHL Medical AG.
8.2.8.1. Company overview
8.2.8.2. Financial performance
8.2.8.3. Product benchmarking
8.2.8.4. Strategic initiatives
8.2.9. Pfizer, Inc.
8.2.9.1. Company overview
8.2.9.2. Financial performance
8.2.9.3. Product benchmarking
8.2.9.4. Strategic initiatives
8.2.10. Amgen Inc.
8.2.10.1. Company overview
8.2.10.2. Financial performance
8.2.10.3. Product benchmarking
8.2.10.4. Strategic initiatives

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings